疫苗安全数据链中孕期疫苗接种与死产关联的评估
该病例对照研究在疫苗安全数据链中按站点、末次月经月份和年份1:4匹配,比较2012至2015年死产与活产妊娠的疫苗接种比值。795例确诊死产与3180例活产中,孕期流感疫苗和Tdap疫苗接种均与死产无显著关联,支持ACIP孕期接种建议的安全性。
要点
- 孕期流感疫苗接种与死产无显著关联(aOR 0.95,95%CI 0.79-1.14)。
- 孕期Tdap疫苗接种与死产无显著关联(aOR 0.96,95%CI 0.76-1.28)。
- 2007至2015年疫苗安全数据链死产率为5.2/1000活产与死产。
核心结论
- 孕期接种流感疫苗或Tdap疫苗与死产 odds 无显著关联,支持ACIP孕期接种建议的安全性。
研究设计与样本
- 疫苗安全数据链中开展的病例对照研究,按站点、末次月经月份和年份1:4匹配。
- 比较2012年1月1日至2015年9月30日间死产(妊娠20周及以后胎儿丢失)与活产妊娠的疫苗接种比值。
- 纳入有至少一次产前检查、妊娠孕周信息和孕期连续健康计划参保的单胎妊娠,并审阅所有死产病历。
- 统计效能可检测流感或Tdap疫苗接种与死产关联的OR为1.37。
- 还分析了2007至2015年疫苗安全数据链中14-49岁孕妇的死产率。
主要发现
- 匹配分析纳入795例确诊死产和3180例活产。
- 孕期流感疫苗接种:死产组343/795(43.1%)vs 活产组1407/3180(44.3%),OR 0.94,aOR 0.95,95%CI 0.79-1.14,P=.54。
- 孕期Tdap疫苗接种:死产组184/795(23.1%)vs 活产组746/3180(23.5%),OR 0.97,aOR 0.96,95%CI 0.76-1.28,P=.91。
- 2007至2015年疫苗安全数据链死产率为5.2/1000活产与死产。
临床怎么用
- 可为孕妇咨询提供依据:孕期接种流感疫苗和Tdap疫苗未增加死产风险。
- 支持按ACIP建议在孕期接种流感疫苗和Tdap疫苗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccinations in pregnancy are associated with increased risk of stillbirth. METHODS: We performed a case-control study in the Vaccine Safety Datalink that was matched 1:4 on site, month, and year of last menstrual period, comparing the odds of vaccination in pregnancies that ended in stillbirth (defined as fetal loss at or after 20 weeks of gestation) compared with those that ended in live birth from January 1, 2012, to September 30, 2015. We included patients with singleton pregnancies that ended in stillbirth or live birth who had at least one prenatal care visit, pregnancy dating information, and continuous health plan enrollment for the duration of pregnancy. Medical records for all stillbirths were reviewed. We were statistically powered to detect an odds ratio (OR) of 1.37 when evaluating the association between influenza or Tdap vaccination and stillbirth. We also examined stillbirth rates in pregnant patients aged 14-49 years in the Vaccine Safety Datalink between 2007 and 2015. RESULTS: In our matched analysis of 795 confirmed stillbirths in the case group and 3,180 live births in the control group, there was no significant association between influenza vaccination during pregnancy and stillbirth (343/795 [43.1%] stillbirths in the case group vs 1,407/3,180 [44.3%] live births in the control group, OR 0.94, adjusted OR 0.95, 95% CI 0.79-1.14, P=.54) and no significant association between Tdap vaccination during pregnancy and stillbirth (184/795 [23.1%] stillbirths in the case group vs 746/3,180 [23.5%] live births in the control group, OR 0.97, aOR 0.96, 95% CI 0.76-1.28, P=.91). From 2007 to 2015, the stillbirth rate in the Vaccine Safety Datalink was 5.2 per 1,000 live births and stillbirths. CONCLUSION: No association was found between vaccination during pregnancy and the odds of stillbirth. These findings support the safety of ACIP recommendations for vaccination during pregnancy.
引用
- Panagiotakopoulos L, McCarthy NL, Tepper NK, et al. Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink. Obstet Gynecol. 2020. PMID: 33156197. doi:10.1097/AOG.0000000000004166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。